Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Rightmove H1 revenue grows on continued demand for products

(Sharecast News) - Online real estate portal operator Rightmove said on Friday that both revenue and operating profits had grown in the six months ended 30 June, driven by continued demand from agents and new home developers. Rightmove said interim revenues were up 7% at £192.1m, as both agents and new home developers renewed contracts, upgraded their packages and invested in additional products.

Operating profits were up 2% at £131.6m, while underlying operating profits were 1% firmer at £135.1m and basic earnings per share were 2% stronger at 12.4p.

The FTSE 100-listed group also declared an interim dividend per share of 3.7%, up 3% year-on-year and said it had returned £100.2m to shareholders via share buybacks and dividends during H1.

Rightmove kept its full-year guidance unchanged and continues to expect revenue growth of 7-9%.

Chief executive Johan Svanstrom said: "We're pleased to deliver a strong set of H1 results, and to be progressing in executing our plan to build an even more valuable digital platform for the UK property industry.

"Our performance came against the backdrop of the sustained challenging mortgage rate environment. The period saw a pick-up in existing-homes listings and transactions, a continued yet softening imbalance of demand and supply for rentals, and a tentative outlook for new homes development volumes. With the election now concluded, the property market looks forward to potential interest rate reductions which will further stimulate activity."

As of 0900 BST, Rightmove shares were down 1.09% at 561.80p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Smith & Nephew appoints Ajay Dhankhar as chief corporate development & strategy officer
(Sharecast News) - Medical technology company Smith & Nephew said on Monday that it has appointed Ajay Dhankhar as chief corporate development & strategy officer with immediate effect.
Oxford Biomedica acquires last 10pc stake in US subsidiary
(Sharecast News) - Oxford Biomedica said on Monday it has acquired the remaining 10% stake in its US subsidiary, OXB US, from Q32 Bio, bringing its ownership of the business to 100% as previously planned.
PPHE acquiring prime London site for hotel development
(Sharecast News) - PPHE Hotel Group has announced the acquisition of a prime development site near the City of London, where it plans to build its first Radisson RED select service hotel in the capital.
Norcros to end tile production in South Africa
(Sharecast News) - Norcros announced on Monday that it will shut down manufacturing at Johnson Tiles South Africa at the end of June, following the conclusion of a strategic review.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.